Defitelio (defibrotide) is an injectable medication used to treat certain complications after a bone marrow transplant, also known as hematopoietic stem cell transplant (HSCT). Defitelio (defibrotide) is infused into the vein (intravenous, IV) by a healthcare provider, and can be given to both children and adults.
Hepatic veno-occlusive disease (VOD), with kidney or lung problems after a bone marrow transplant
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.